Search Results - "Kudashkin, N E"

Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel by Breder, V. V., Alikhanov, R. B., Bagnenko, S. S., Bessonova, E. N., Isakov, V. A., Kudashkin, N. E., Medvedeva, B. M., Mishchenko, A. V., Novruzbekov, M. S., Rudakov, V. S. 

“…А im: to describe modern approaches for screening and early diagnosis of hepatocellular carcinoma (HCC). Key points. Screening for HCC in high-risk groups…”
Get full text

Irreversible electroporation in locally advanced pancreatic cancer by Polyakov, A N, Patyutko, Yu I, Kudashkin, N E, Kantieva, D M, Romanova, K A, Nasonova, E A, Korshak, A V, Egenov, O A, Podluzhnyi, D V

“…To determine the feasibility of irreversible electroporation (IRE) for locally advanced pancreatic adenocarcinoma. Twenty-three patients underwent IRE after…”
Get more information

Repeated irreversible electroporation in a locally advanced pancreatic cancer by A. N. Polyakov, D. V. Podluzhnyi, N. E. Kudashkin, I. S. Bazin, B. M. Medvedeva, A. Yu. Syskova, D. M. Kantieva, Yu. I. Patyutko

“…It is reasonable to consider the technical possibility and oncological feasibility of the local tumor destruction in patients with locally advanced pancreatic…”
Get full text

Methods for the detection of tumor-specific single nucleotide somatic mutations in plasma cDNA samples by Dyakov, L. M., Krivtsova, O. M., Khesina, P. A., Kustova, I. F., Dyakova, N. A., Muge, N. S., Kudashkin, N. E., Patyutko, Yu. I., Lazarevich, N. L.

“…Introduction . Liquid biopsy is considered as a minimally invasive method of molecular genetic analysis that can be used for early diagnosis, prognosis of…”
Get full text

Prognostic value of the proportion of the sclerosing component in fibrolamellar liver carcinoma by Antonova, E. Yu, Moroz, E. A., Podluzhny, D. V., Kudashkin, N. E., Dzhanyan, I. A., Volkov, A. Yu, Laktionov, K. K., Breder, V. V.

“…Introduction . Fibrolamellar hepatocellular carcinoma (FLC), which develops most often in the younger population. In FLC, variable histoarchitectonics are…”
Get full text

Liver Functional Evaluation Using Gadoxetic Acid Versus the Gold Standard Hepatobiliary Scintigraphy in Patients with Bile Duct Diseases by Shorikov, M. A., Sergeeva, O. N., Kashkadaeva, A. V., Averinova, S. G., Lapteva, M. G., Frantsev, D. Yu, Polyakov, A. N., Kudashkin, N. E., Alekhin, A. P., Moroz, E. A., Virshke, E. R., Dolgushin, B. I.

“…Objective. To compare liver function assessments using Gd-EOB-DTPA-enhanced MRI and the gold standard hepatobiliary scintigraphy (HBS) in patients with bile…”
Get full text

Identification of a new methylation site in the Sept9 promoter region for the diagnosis of hepatocellular carcinoma by Lazarevich, N. L., Abramov, P. M., Fedorova, M. D., Kustova, I. F., Shavochkina, D. A., Katargin, A. N., Kisseljova, N. P., Dyakova, N. A., Botezatu, I. V., Kondratova, V. N., Kudashkin, N. E., Patyutko, Yu. I., Lichtenstein, A. V., Vinokurova, S. V.

“…Background. Over 600,000 people die from hepatocellular carcinoma (HCC) each year worldwide. The disease is often detected at advanced stages and in many cases…”
Get full text

HEPATOCELLULAR CARCINOMA AS A SOCIAL AND MEDICAL PROBLEM IN THE RUSSIAN FEDERATION by V. V. BREDER, V. Y. KOSYREV, N. E. KUDASHKIN, K. K. LAKTION

“…The prevalence of risk factors for HCC in the Russian population is reflected in a significant potential growth in morbidity. In the absence of active…”
Get full text

Celiac trunk resection in patients with pancreatic cancer and severe pain syndrome by Patyutko, Yu I, Abgaryan, M G, Kudashkin, N E, Kotelnikov, A G

“…To show the advisability, satisfactory tolerance and good analgesic effect of surgery for pancreatic ductal carcinoma with celiac trunk invasion. Distal…”
Get more information

Total pancreatectomy for pancreatic cancer by Patyutko, Yu I, Kudashkin, N E, Kotel'nikov, A G, Chistyakova, O V

“…to determine the indications and to evaluate early and long-term outcomes of total pancreatectomy for pancreatic cancer. Treatment of 29 patients who underwent…”
Get more information

Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinoma by Chesnokov, M. S., Krivtsova, O. M., Skovorodnikova, P. A., Makarova, A. S., Kustova, I. F., Logacheva, M. D., Penin, A. A., Klepikova, A. V., Shavochkina, D. A., Kudashkin, N. E., Moroz, E. A., Patyutko, Y. I., Kotelnikova, E. A., Lazarevich, N. L.

“…Aim. Identification of candidate secreted biomarkers for hepatocellular carcinoma (HCC) diagnosis. Methods. Genes upregulated in HCC tissue and encoding…”
Get full text

NGS-based identification of druggable alterations and signaling pathways - hepatocellular carcinoma case report by Kotelnikova, E. A., Logacheva, M. D., Nabieva, E. R., Pyatnitskiy, M. A., Vinogradov, D. V., Makarova, A. S., Demin, A. V., Paleeva, A. G., Kremenetskaya, O. S., Penin, A. A., Klepikova, A. V., Kasianov, A. S., Shavochkina, D. A., Kudashkin, N. E., Patyutko, Yu. I., Mugue, N. S., Kondrashov, A. S., Lazarevich, N. L

“…Aim. To identify potential cancer driving or clinically relevant molecular events for a patient with hepatocellular carcinoma. Methods. In order to achieve…”
Get full text

Central or distal pancreatectomy in patients with pancreatic tumors: assessment of short‑term outcomes by T.  S.  Mirzaev, D.   V. Podluzhniy, R.  E.  Izrailov, A.   G. Kotelnikov, E.  V.  Glukhov, I.  M.  Faynshteyn, P.  A.  Kerimov, N.  E.  Kudashkin, A.  N.  Polyakov, B.  I.  Sakibov

“…Objective: to compare short-term and long-term postoperative complications between patients who have undergone central pancreatectomy (CP) and distal…”
Get full text

Concordance between the tumor mutational status and circulating tumor DNA in patients with colorectal cancer by E. M. Polyanskaya, M. Yu.  Fedyanin, U. A. Boyarskikh, A. A. Kechin, E. A. Moroz, A. N. Polyakov, N. E. Kudashkin, D. V. Podluzhniy, E. A. Khrapov, I. P. Oskorobin, D. V. Shamovskaya, V. A. Aliev, Z. Z. Mamedli, A. A. Tryakin, M. L. Filipenko, S. A. Tjulandin

“…Background. Circulating tumor DnA (ctDnA) may act as a potential biomarker for predicting disease progression in patients with colorectal cancer (CRC), which…”
Get full text

The proximal and distal body-preserving resection of the pancreas by Patiutko, Iu I, Kudashkin, N E, Poliakov, A N, Abirov, K A, Podluzhnyi, D V

Get more information

Second line drug therapy for biliary cancer by Savchenko, I. V., Breder, V. V., Stilidi, I. S., Laktionov, K. K., Kudashkin, N. E., Egorova, A. V., Chulkova, S. V.

“…Biliary cancer is a group of tumors that develop from the epithelium of the intra- and extrahepatic bile ducts (cholangiocarcino-ma), as well as the…”
Get full text

Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablation by Breder, V. V., Pokataev, I. A., Petkau, V. V., Fedyanin, M. Yu, Ledin, E. V., Zagainov, V. E., Shapoval, S. V., Granov, D. A., Balakhnin, P. V., Kudashkin, N. E., Pogrebnyakov, I. V., Popova, N. V., Moroz, E. A.

“…MEETING DATE: July 7, 2023 ITEMS ON THE AGENDA: 1. The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma (HCC) at…”
Get full text

Resection of liver segments VII-VIII: is right hepatic vein reconstruction advisable? by Patyutko, Yu I, Podluzhny, D V, Polyakov, A N, Nasonova, E A, Kudashkin, N E

“…To improve the treatment outcomes in patients with primary and metastatic liver tumors localized in segments VII-VIII involving the right hepatic vein and its…”
Get more information

The role of molecular genetic factors in the development of cholangiocellular carcinoma by Chulkova, S V, Loginov, V I, Podluzhnyi, D V, Egorova, A V, Syskova, A Yu, Semichev, D G, Gladilina, I A, Kudashkin, N E

“…The article lists the main inducers of cholangiocarcinogenesis. The main inflammatory mediators (IL-6, nitric oxide, COX2) have been considered. Data on the…”
Get more information

Irreversible electroporation of locally advanced unresectable pancreatic cancer by Yu I Patyutko, A N Polyakov, N E Kudashkin, D V Podluzhnyi, O V Chistyakova

“…Aim: to improve the results of treatment of patients with locally advancesd pancreatic cancer. Matherials and methods. From February 2015 till June 2017 there…”
Get full text